Paperpal Prime Logo

Current Opinion in Oncology : Impact Factor & More

eISSN: 1531-703XpISSN: 1040-8746

Key Metrics

CiteScore
5.6
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q1Medicine (all)
SNIP
1.22
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Opinion in Oncology

Current Opinion in Oncology Journal Specifications

Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1989
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Current Opinion in Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Opinion in Oncology

Editorial introductions
  • 8 Oct 2026
  • Current Opinion in Oncology
Electronic patient-reported outcomes platforms to shift from episodic to continuous oncology in breast cancer.
  • 1 Oct 2026
  • Current opinion in oncology
Time-of-day administration of immune checkpoint inhibitors: current clinical evidence and future directions for breast cancer.
  • 1 Oct 2026
  • Current opinion in oncology
Adjuvant treatments for stage I breast cancers of one centimeter or less.
  • 22 Sep 2026
  • Current opinion in oncology
Precision medicine for pediatric gliomas.
  • 19 Sep 2026
  • Current opinion in oncology
Beyond poly(ADP-ribose) polymerase inhibition: emerging therapeutic strategies for germline BRCA1/2 -mutated and PALB2 -mutated breast cancers.
  • 19 Sep 2026
  • Current opinion in oncology
Editorial introductions
  • 8 Oct 2026
  • Current Opinion in Oncology
Electronic patient-reported outcomes platforms to shift from episodic to continuous oncology in breast cancer.
  • 1 Oct 2026
  • Current opinion in oncology
Time-of-day administration of immune checkpoint inhibitors: current clinical evidence and future directions for breast cancer.
  • 1 Oct 2026
  • Current opinion in oncology
Adjuvant treatments for stage I breast cancers of one centimeter or less.
  • 22 Sep 2026
  • Current opinion in oncology
Precision medicine for pediatric gliomas.
  • 19 Sep 2026
  • Current opinion in oncology
Beyond poly(ADP-ribose) polymerase inhibition: emerging therapeutic strategies for germline BRCA1/2 -mutated and PALB2 -mutated breast cancers.
  • 19 Sep 2026
  • Current opinion in oncology

FAQs on Current Opinion in Oncology